Drug Ther Bull. 2009 Oct;47(10):110-3. doi: 10.1136/dtb.2009.09.0042.
Heart failure is common, causes major disability and often shortens life. Two UK guidelines advocate the measurement of plasma concentrations of B-type natriuretic peptide (BNP) in diagnosis of chronic heart failure, either in combination with, or as an alternative to, an ECG.1,2 Here we review the evidence for BNP testing in the diagnosis of chronic heart failure, and discuss the implications in terms of availability of the test.
心力衰竭很常见,会导致严重残疾,而且常常缩短寿命。英国的两份指南提倡在慢性心力衰竭的诊断中测定血浆B型利钠肽(BNP)浓度,可与心电图联合使用,也可替代心电图。1,2 在此,我们回顾了BNP检测在慢性心力衰竭诊断中的证据,并讨论了该检测的可及性方面的影响。